Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.05 par value
-
Shares outstanding
-
2K
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
+278K
-
Total reported value, excl. options
-
$360M
-
Value change
-
+$8.08M
-
Put/Call ratio
-
2.05
-
Number of buys
-
54
-
Number of sells
-
-69
-
Price
-
$29.71
Significant Holders of SURMODICS INC - Common Stock, $0.05 par value (SRDX) as of Q2 2025
160 filings reported holding SRDX - SURMODICS INC - Common Stock, $0.05 par value as of Q2 2025.
SURMODICS INC - Common Stock, $0.05 par value (SRDX) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
.
Largest 10 shareholders include BlackRock, Inc. (1.15M shares), ALLIANCEBERNSTEIN L.P. (850K shares), VANGUARD GROUP INC (810K shares), Soleus Capital Management, L.P. (789K shares), MORGAN STANLEY (656K shares), READYSTATE ASSET MANAGEMENT LP (434K shares), UBS Group AG (423K shares), GABELLI FUNDS LLC (415K shares), Hudson Bay Capital Management LP (400K shares), and Qube Research & Technologies Ltd (394K shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.